News Kite keeps pressure on Novartis with CAR-T filing Kite completes filing a day after rival Novartis.
News NHS to axe 18-week ops waiting target Cancer care and mental health to take priority, says health chief.
News AZ's Tagrisso gets full US approval in lung cancer Phase 3 data confirmed its efficacy in patients with a certain mutation.
News Novartis edges ahead in CAR-T race Novartis has filed its CAR-T cell therapy with the FDA, giving it an edge over Kite Pharma and its rival treatment.
News Tesaro's niraparib approved in ovarian cancer Company nabs maintenance therapy use, but problems on breast cancer trial.
News Keytruda in new lymphoma use leads latest CHMP decisions MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
Digital An AI supercomputer and discovering next-gen brain disorder ... Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
